CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | Leonard Braden Michael 10% owner | Purchase | +216,053 | $1.26 | $272K | 4,471,380 |
| 2024-02-05 | Golipour Azadeh Chief Technology Officer | Shares withheld for taxes | −12,232 | $1.20 | $15K | 55,872 |
| 2024-02-05 | Ridha Essra Chief Medical Officer | Shares withheld for taxes | −16,953 | $1.20 | $20K | 15,881 |
| 2024-02-05 | Ostrowski Erik Interim CEO, President and CFO | Shares withheld for taxes | −13,099 | $1.20 | $16K | 29,285 |
| 2024-02-05 | Avruch Steven Chief Legal Officer | Shares withheld for taxes | −10,812 | $1.20 | $13K | 22,022 |
| 2024-02-01 | Golipour Azadeh Chief Technology Officer | Option exercise | +37,334 | 68,104 | ||
| 2024-02-01 | Golipour Azadeh Chief Technology Officer | Option exercise · Restricted Stock Unit | −37,334 | 111,999 | ||
| 2024-02-01 | Ridha Essra Chief Medical Officer | Option exercise | +32,834 | 32,834 | ||
| 2024-02-01 | Ridha Essra Chief Medical Officer | Option exercise · Restricted Stock Unit | −32,834 | 98,499 | ||
| 2024-02-01 | Ostrowski Erik Interim CEO, President and CFO | Option exercise | +40,084 | 42,384 | ||
| 2024-02-01 | Ostrowski Erik Interim CEO, President and CFO | Option exercise · Restricted Stock Unit | −40,084 | 120,249 | ||
| 2024-02-01 | Avruch Steven Chief Legal Officer | Option exercise | +32,834 | 32,834 | ||
| 2024-02-01 | Avruch Steven Chief Legal Officer | Option exercise · Restricted Stock Unit | −32,834 | 98,499 | ||
| 2023-07-01 | Ostrowski Erik Interim CEO, President and CFO | Grant or award · Restricted Stock Unit | +70,000 | 70,000 | ||
| 2023-06-12 | Golipour Azadeh Chief Technology Officer | Shares withheld for taxes | −5,463 | $1.19 | $7K | 30,881 |
| 2023-06-12 | Golipour Azadeh Chief Technology Officer | Shares withheld for taxes | −111 | $1.21 | $134 | 30,770 |
| 2023-06-06 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +17,643 | 17,643 | ||
| 2023-06-06 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +17,643 | 17,643 | ||
| 2023-06-06 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +17,643 | 17,643 | ||
| 2023-06-06 | Farfel Gail M Director | Grant or award · Stock Option (Right to Buy) | +17,643 | 17,643 |
Page 9 of 10 · 188 trades